Gr. Sarantis Toekomstige groei

Future criteriumcontroles 2/6

Gr. Sarantis zal naar verwachting groeien in winst en omzet met respectievelijk 12.6% en 5.8% per jaar. De winst per aandeel zal naar verwachting groeien met 12.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 14.7% zijn.

Belangrijke informatie

12.6%

Groei van de winst

12.4%

Groei van de winst per aandeel

Personal Products winstgroei	6.9%
Inkomstengroei	5.8%
Toekomstig rendement op eigen vermogen	14.7%
Dekking van analisten	Good
Laatst bijgewerkt	01 Nov 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

LSE:0IIO - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	663	66	65	81	5
12/31/2025	630	56	59	76	5
12/31/2024	596	48	-10	52	6
6/30/2024	552	44	47	58	N/A
3/31/2024	517	42	50	59	N/A
12/31/2023	482	39	52	59	N/A
9/30/2023	473	37	45	52	N/A
6/30/2023	465	34	37	45	N/A
3/31/2023	455	30	25	34	N/A
12/31/2022	445	26	12	23	N/A
9/30/2022	434	27	10	25	N/A
6/30/2022	424	28	8	28	N/A
3/31/2022	415	29	14	39	N/A
12/31/2021	406	31	20	50	N/A
9/30/2021	406	34	13	42	N/A
6/30/2021	405	38	5	33	N/A
3/31/2021	399	38	5	32	N/A
12/31/2020	393	39	4	32	N/A
9/30/2020	387	39	8	34	N/A
6/30/2020	382	40	12	36	N/A
3/31/2020	376	39	9	28	N/A
12/31/2019	370	38	6	20	N/A
9/30/2019	363	36	1	15	N/A
6/30/2019	356	34	-4	11	N/A
3/31/2019	350	33	-3	11	N/A
12/31/2018	344	33	-1	11	N/A
9/30/2018	329	30	4	15	N/A
6/30/2018	314	27	10	20	N/A
3/31/2018	307	28	N/A	24	N/A
12/31/2017	300	29	N/A	28	N/A
9/30/2017	308	29	N/A	22	N/A
6/30/2017	315	29	N/A	15	N/A
3/31/2017	322	27	N/A	13	N/A
12/31/2016	329	25	N/A	10	N/A
9/30/2016	323	25	N/A	11	N/A
6/30/2016	306	23	N/A	12	N/A
3/31/2016	303	22	N/A	12	N/A
12/31/2015	279	20	N/A	12	N/A
9/30/2015	266	19	N/A	14	N/A
6/30/2015	260	17	N/A	15	N/A
3/31/2015	253	17	N/A	7	N/A
12/31/2014	248	17	N/A	9	N/A
9/30/2014	247	15	N/A	9	N/A
6/30/2014	242	14	N/A	9	N/A
3/31/2014	237	15	N/A	13	N/A
12/31/2013	236	16	N/A	17	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei 0IIO ( 12.6% per jaar) ligt boven de spaarquote ( 2.1% ).

Winst versus markt: De winst van 0IIO ( 12.6% per jaar) zal naar verwachting langzamer groeien dan de markt UK ( 14.6% per jaar).

Hoge groeiwinsten: De winst van 0IIO zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van 0IIO ( 5.8% per jaar) zal naar verwachting sneller groeien dan de markt UK ( 3.6% per jaar).

Hoge groei-inkomsten: De omzet van 0IIO ( 5.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen 0IIO zal naar verwachting over 3 jaar laag zijn ( 14.7 %).

Gr. Sarantis Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Gr. Sarantis S.A. Not to Provide Financial Guidance for the Fiscal Year of 2020

Recent updates

Executive Chairman recently bought €315k worth of stock

Executive Chairman recently bought €544k worth of stock

First half 2024 earnings released: EPS: €0.38 (vs €0.29 in 1H 2023)

Executive Chairman recently bought €110k worth of stock

Less than half of directors are independent

Gr. Sarantis S.A. to Report First Half, 2024 Results on Sep 03, 2024

Full year 2023 earnings released: EPS: €0.59 (vs €0.39 in FY 2022)

Gr. Sarantis S.A. to Report Fiscal Year 2023 Results on Mar 11, 2024

Less than half of directors are independent

Less than half of directors are independent

Gr. Sarantis S.A., Annual General Meeting, Dec 20, 2023

Less than half of directors are independent

Gr. Sarantis S.A. to Report Nine Months, 2023 Results on Nov 07, 2023

Gr. Sarantis S.A. to Report First Half, 2023 Results on Sep 11, 2023

Less than half of directors are independent

New minor risk - Shareholder dilution

Less than half of directors are independent

New minor risk - Profit margin trend

Less than half of directors are independent

Less than half of directors are independent

Gr. Sarantis S.A. to Report First Half, 2022 Results on Sep 08, 2022

Less than half of directors are independent

An unknown buyer agreed to acquire 49% stake in ELCA Cosmetics Limited for €55.2 million.

Less than half of directors are independent

Gr. Sarantis S.A., Annual General Meeting, May 24, 2022

Less than half of directors are independent

Gr. Sarantis S.A. to Report Fiscal Year 2021 Results on Apr 29, 2022

Less than half of directors are independent

Less than half of directors are independent

Vice Chairman & CEO recently bought €86k worth of stock

Gr. Sarantis S.A. (ATSE:SAR) announces an Equity Buyback for 4,222,844 shares, representing 6.04% for €63.34 million.

Less than half of directors are independent

First half 2021 earnings released: EPS €0.29 (vs €0.23 in 1H 2020)

Less than half of directors are independent

Vice Chairman & CEO recently bought €915k worth of stock

Vice Chairman & CEO recently bought €69k worth of stock

Full year 2020 earnings released: EPS €0.58 (vs €0.57 in FY 2019)

Gr. Sarantis S.A. to Report Fiscal Year 2020 Results on Apr 08, 2021

Vice Chairman & CEO recently bought €96k worth of stock

Vice Chairman & CEO recently bought €118k worth of stock

Vice Chairman & CEO recently bought €51k worth of stock

Mehmet Yigit Sardan will acquire 15% interest in Sarantis Anadol from Sarantis.

Gr. Sarantis S.A. Not to Provide Financial Guidance for the Fiscal Year of 2020

Gr. Sarantis S.A. to Report First Half, 2020 Results on Sep 02, 2020

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven